Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
Your Article Summary
See Latest ArticlesAdvances in the treatment of pancreatic cancer: Limitations of surgery and evaluation of new therapeutic strategies
Surgery Today, 05/28/09
Yokoyama Y et al. - The survival benefits of aggressive surgery have been denied by most randomized controlled trials. This implies that surgery alone is not enough. Thus, adjuvant therapy, such as radiotherapy and chemotherapy, has been given in combination with surgery to improve survival. Although the benefits of radiotherapy alone are limited, the results of chemotherapy are promising. Other newly evolving molecular targeting drugs may also improve the treatment outcomes of pancreatic cancer.
Related Articles
Real-time and the in vivo detection of minute cancer invasion to the portal-superior mesenteric vein using contact endoscopy during a pancreatic cancer resection
The American Journal of Surgery, 11/06/09
Relevance Score: 70%
In vitro and in vivo evidence that a combination of lapatinib plus S-1 is a promising treatment for pancreatic cancer
Cancer Science, 12/04/09
Relevance Score: 69%
Clinical significance of vascular endothelial growth factor and connexin43 for predicting pancreatic cancer clinicopathologic parameters
Medical Oncology, 11/19/09
Relevance Score: 69%
A Novel Role of Interleukin-13 Receptor 2 in Pancreatic Cancer Invasion and Metastasis
Cancer Research, 11/17/09
Relevance Score: 69%
Genetic variation in CYP17A1 and pancreatic cancer in a population-based case-control study in the San Francisco Bay Area, California
International Journal of Cancer, 11/05/09
Relevance Score: 69%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Efficacy and Safety of Transarterial Chemoembolization in Recurrent Hepatocellular Carcinoma After Curative Surgical Resection
American Journal of Clinical Oncology, 12/07/09
New developments in the preoperative evaluation and perioperative management of coronary artery disease in patients undergoing vascular surgery
Journal of Vascular Surgery, 12/04/09
Pre-implantation Basiliximab Reduces Incidence of Early Acute Rejection in Pediatric Heart Transplantation
The Journal of Heart and Lung Transplantation, 12/04/09
Today in Hepatobiliary/Pancreas...keeping you current
Receive free subspecialty "5-minute updates" via email
End-stage nonalcoholic fatty liver disease: evaluation of pathomorphologic features and relationship to cryptogenic cirrhosis from study of explant livers in a living donor liver transplant program
Human Pathology, 12/07/09
Efficacy and Safety of Transarterial Chemoembolization in Recurrent Hepatocellular Carcinoma After Curative Surgical Resection
American Journal of Clinical Oncology, 12/07/09
Insertion and management of percutaneous veno-venous bypass cannula for liver transplantation: a reference for transplant anesthesiologists
Clinical Transplantation, 12/07/09
Today in Surgical Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
A Pilot Prospective Randomized Trial of Postoperative Epoetin Alfa in Patients Undergoing Major Operation for Upper Gastrointestinal Malignancy
American Journal of Clinical Oncology, 12/07/09
Efficacy and Safety of Transarterial Chemoembolization in Recurrent Hepatocellular Carcinoma After Curative Surgical Resection
American Journal of Clinical Oncology, 12/07/09
Optimal surgery for advanced gastric cancer
Expert Review of Anticancer Therapy, 12/07/09
Sponsor
Article Search
Sponsor